Ginkgo Going Public with ~1.63B in Proceed Via Soaring Eagle SPAC Merger
Shots:
- The merger was approved in a shareholder vote with 75% participation & 97% in favor of the combination. Upon the closing of the merger- Ginkgo is eligible to receive ~1.63B in gross proceeds including $775M from a PIPE and ~$858M from the Soaring Eagle trust account
- Soaring Eagle will now change its name to Ginkgo Bioworks and the combined company’s shares of Class A common stock will trade on NYSE under the ticker symbols “DNA and DNA.WS” respectively
- Ginkgo has built a platform for cell programming that can be used by companies across multiples industries to develop products such as food ingredients- fragrances- cosmetics & medicines respectively
| Ref: Businesswire | Image: PR Newswire
Click here to read the full press release
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com